HeartSciences

HeartSciences

Open  for investment

About this raise

HeartSciences is raising funds through Reg A+ crowdfunding with Digital Offering as the Broker-Dealer. The company is developing the first-of-its-kind AI-ECG technology for early detection of heart diseases. HeartSciences is developing ECG device hardware, cloud-native software, and AI-ECG algorithms that deliver health solutions across a variety of healthcare settings for comprehensive AI-ECG solutions. The company has 43 patents and is receiving validation from top names in the healthcare industry. Drew Diaz and Guangren Chen founded HeartSciences in 2007. The current crowdfunding campaign has a maximum target of $37.7 million. The campaign proceeds will be used for sales and marketing, inventory, operations, administrative expenses, research and development, and debt repayment.

Expand

Investment Overview

Committed this round: $47,873

Deal Terms

Platform
Digital Offering
Start Date
03/10/2025
Close Date
Not Provided
Min. Goal
$675
Max Goal
$37,714,280
Min. Investment

$675

Security Type

Equity - Preferred

Company Stage

Growth Stage

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$3.50

Company & Team

Company

Year Founded
2007
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
High
Location
Southlake, Texas
Business Type
High Growth
Company Website
Visit Website

Team

Employees
15
Prior Founder Exits?
No
Founder Name
Drew Diaz
Title
President - Field Operations

Funding data not publicly available

Financials

 Revenue
$0
 Monthly Burn
$344,551
 Runway
11.8 months

Balance Sheet

Cash and Cash Equivalents

$4,052,120

Investment Securities

$0

Accounts and Notes Receivable

$0

Property, Plant and Equipment (PP&E)

$77,069

Property and Equipment

$77,069

Total Assets

$7,777,241

Long Term Debt

$2,416,270

Total Liabilities

$3,760,520

Total Stockholders' Equity

$4,016,721

Total Liabilities and Equity

$7,777,241

Statement of Comprehensive Income Information

Total Revenues

$0

Costs & Expenses Applicable to Rev

$0

Depreciation and Amortization

$24,079

Net Income

$-4,134,607

Earnings Per Share - Basic

$-4.88

Earnings Per Share - Diluted

$-4.88

Auditor: Haskell & White LLP
Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Total Prior Capital Raised
$33,200,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
03/10/2026 Digital Offering - $47,873 Equity - Preferred Active RegA+
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
HeartSciences on Digital Offering 2025
Platform: Digital Offering
Security Type: Equity - Preferred
Price per Share: $3.50

Follow company

Follow HeartSciences on Digital Offering 2025

Buy HeartSciences's Deal Report

HeartSciences Deal Report

Get Kingscrowd's comprehensive report on HeartSciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether HeartSciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the HeartSciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge